Infantile exanthematous disease with elevated anti-toxic shock syndrome toxin-1 antibody: Related to toxic shock syndrome toxin-1 ?

Pediatrics International

Volumn 42, Issue 2, 2000, Pages 178-180

  Imai, Chihaya ^a   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Infant; Kawasaki disease; Methicillin resistant Staphylococcus aureus; Neonatal toxic shock syndrome like exanthematous disease; Toxic shock syndrome toxin 1

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; STAPHYLOCOCCUS TOXIN;

ARTICLE; BACTERIAL INFECTION; CASE REPORT; CHILDHOOD DISEASE; DISEASE ASSOCIATION; HUMAN; INFANT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RASH; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

ANTIBODIES; BACTERIAL TOXINS; ENTEROTOXINS; EXANTHEMA; HUMANS; INFANT; MALE; SHOCK, SEPTIC; SUPERANTIGENS;

EID: 0034096792     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01188.x     Document Type: Article

References (10)

1. 1 Choi Y, Lafferty JA, Clements JR et al. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 1990; 172: 981-4.
2. 2 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705-11.
3. 3 Miethke T, Duschek K, Wahl C. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 1993; 23: 1494-500.
4. 4 Abe J, Kotzin BL, Jujo K et al. Selective expansion of T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl Acad. Sci. USA 1992; 89: 4066-70.
5. 5 Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 1995; 72: 308-11.
6. 6 Terai M, Miwa K, Williams T et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J. Infect. Dis. 1995; 172: 558-61.
7. 7 Takahashi N, Nishida H, Kato H, Imanishi K, Sakata Y, Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998; 351: 1614-19.
8. 8 Nadal D, Hunziker UA, Bauersfeld U, Pfister H, Hitzig WH. Infection with Staphylococcus aureus producing toxic shock syndrome (TSS) toxin-1 without TSS. Eur. J. Pediatr. 1989; 148: 318-19.
9. 9 Johnson WM, Tyler SD, Ewan EP, Ashton FE, Pollard DR, Rozee KR. Detection of genes for enterotoxins, exofoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J. Clin. Microbiol. 1991; 29: 426-30.
10. 10 Kimura A, Igarashi H, Ushioda H, Okuzumi K, Kobayashi H, Otsuka T. Epidemiological study of Staphylococcsus aureus isolated from the Japanese National University and Medical College Hospitals with coagulase typing, and production of enterotoxin and toxic shock syndrome toxin-1. J. Jpn. Assoc. Infect. Dis. 1992; 66: 1543-9 (in Japanese).